Latest Articles
Over 960 women on waitling lists for endometriosis care across five hospitals - BreakingNews.ie
Over 960 women on waitling lists for endometriosis care across five hospitals BreakingNews.ie
Published: Aug. 8, 2026, 7:23 a.m.
Over 960 women on waiting lists for endometriosis care across five hospitals - BreakingNews.ie
Over 960 women on waiting lists for endometriosis care across five hospitals BreakingNews.ie
Published: Aug. 8, 2026, 7:23 a.m.
Over 960 women on waiting lists for endometriosis care across five hospitals - roscommonherald.ie
Over 960 women on waiting lists for endometriosis care across five hospitals roscommonherald.ie
Published: Aug. 8, 2026, 7:23 a.m.
Over 960 women on waiting lists for endometriosis care across five hospitals - kildare-nationalist.ie
Over 960 women on waiting lists for endometriosis care across five hospitals kildare-nationalist.ie
Published: Aug. 8, 2026, 7:23 a.m.
'Feeling heard is everything': endometriosis advocate's advice to worried women - The Examiner
'Feeling heard is everything': endometriosis advocate's advice to worried women The Examiner
Published: Aug. 8, 2026, 4:44 a.m.
[The Laterality of Endometriosis].
Endometriosis, affecting 10-15% of women of reproductive age, is more commonly found on the left side of the pelvis. This laterality phenomenon's etiology remains obscure. We reviewed the existing literature …
Published: Aug. 7, 2026, midnight
When endometriosis hides in plain sight: how advanced robotic surgery is helping women reclaim their lives - The Guardian
When endometriosis hides in plain sight: how advanced robotic surgery is helping women reclaim their lives The Guardian
Published: Aug. 6, 2026, 3:32 p.m.
When endometriosis hides in plain sight: how advanced robotic surgery is helping women reclaim their lives - theguardian.com
When endometriosis hides in plain sight: how advanced robotic surgery is helping women reclaim their lives theguardian.com
Published: Aug. 6, 2026, 3:32 p.m.
Opal Therapeutics Secures $1.25M NSF SBIR Phase II Award to Accelerate Women’s Health Drug Discovery - Business Wire
Opal Therapeutics Secures $1.25M NSF SBIR Phase II Award to Accelerate Women’s Health Drug Discovery Business Wire
Published: Aug. 6, 2026, 10:30 a.m.
Opal Therapeutics Secures $1.25M NSF SBIR Phase II Award to Accelerate Women’s Health Drug Discovery - businesswire.com
Opal Therapeutics Secures $1.25M NSF SBIR Phase II Award to Accelerate Women’s Health Drug Discovery businesswire.com
Published: Aug. 6, 2026, 10:30 a.m.
Link copied to clipboard!